Takeshi Hirose

机构：Memorial Sloan Kettering Cancer Center, Tokyo Health Care University · ORCID：0000-0003-1588-9757

发表论文 220 篇 · 总被引 2772 次 · h-index 25

代表论文

• Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma (2019 · Oncogene · 被引 69)
• Extensive functional evaluation of exon 20 insertion mutations of EGFR (2020 · Lung Cancer · 被引 24)
• Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterogeneous tumor model (2022 · Oncogene · 被引 16)
• The treatment landscape of advanced angiosarcoma in Asia—A multi‐national collaboration from the Asian Sarcoma Consortium (2021 · Cancer Science · 被引 16)
• Viable tumor cell density after neoadjuvant chemotherapy assessed using deep learning model reflects the prognosis of osteosarcoma (2024 · npj Precision Oncology · 被引 15)
• Short-term clinical outcomes of Kyocera Modular Limb Salvage System designed cementless stems for the endoprosthetic reconstruction of lower extremities: a Japanese Musculoskeletal Oncology Group multi-institutional study (2022 · BMC Cancer · 被引 13)